Chip stocks fell on Thursday after President Donald Trump's 'Liberation Day' tariffs were announced on trading partners, ...

Car buyers in India will soon have to pay more, as leading automakers plan to raise vehicle prices starting April 2025. Automakers such as Maruti Suzuki, Mahindra & Mahindra, Hyundai, and others have ...

Kia India, Honda Cars India, Renault India and BMW have also announced to hike vehicle prices from the next month. Maruti, meanwhile, is eying a 4% hike.

Under the deal, Hormazd will continue to oversee the flagship automotive titles Autocar India, Autocar Professional, and What Car? India. The cash and equity deal sees Haymarket remain invested in ...

MG Motor India is set to ace up its line-up with the ... Well, wondering what are the cars we are talking about? Read on to find out. The MG Cyberster 2025 is anticipated to steal the show in ...

Honda Cars India will increase prices across all models from April 2025 due to rising input costs and operational expenses. The hike will vary by model and variant. Other automakers like Maruti Suzuki ...

Honda Cars India has followed the footsteps of carmakers like Maruti Suzuki, Tata Motors, Kia and Hyundai by announcing a price hike for its passenger vehicles in the country, effective from April ...

European carmakers are redrawing their India 2.0 strategies as the country's automobile market gains heft, with immense scope for value appreciation. India is the third-largest car market, trailing ...

The source also stated that Tesla is open to increasing its allocations to India if the government permits it and further reduces duty rates. “As per the current EV policy, 8,000 units can be imported ...

The CAR-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect the bone marrow and the lymphatic system. Listen to Story India's first Car ...

“The clinical trials of India’s CAR T-cell therapy provide an additional treatment option for such patients,” said Rahul Purwar, professor at IIT Bombay and founder of ImmunoACT, a company ...

The decision comes in response to the escalating input costs and rising operational expenses, impacting the company's profitability. This is the third instance of India's largest passenger car ...